Aquatic Veterinary Market Report: Size, Share and Outlook by 2031

The aquatic veterinary market size is projected to reach US$ 1.54 billion in 2024 to US$ 2.00 billion by 2031; the market is expected to register a CAGR of 7.57% during 2025-2031. Major factors driving the market growth include a surging demand for seafood products and expanding aquaculture industry are noteworthy factors contributing to the market growth Further, the advancements in genomic and biotechnological approaches for aquatic veterinary is likely to boost the market during the forecast period. However, data privacy vulnerabilities among the market deterrents.

In 2022, the US FDA issued the Center for Veterinary Medicine Aquaculture Strategic Plan (2022-2026), with emphasis on drug approvals and antimicrobial stewardship so that veterinarians are duly equipped with products to achieve safe and effective treatments of aquatic diseases. Alongside, the 2022 US Omnibus Bill allocated US$5 million to facilitate the USDA Aquatic Animal Health Program for enhancement of biosecurity, surveillance, and education of the farmers under the National Aquaculture Health Plan, directly potently working for veterinarians preventing diseases with the help of resources.

In Europe, the Cure4Aqua project was launched in 2022 with funding of US$5.13 million by Horizon Europe, an EU program, and shall last 4.5 years. The project pursues the study of new approaches to protecting against fish diseases in aquatic systems. It will also implement and test new technologies for the early detection of diseases while fostering the development and testing of alternative treatments that could replace the use of pharmaceuticals in disease control.

Therefore, the surging government initiatives supporting aquatic veterinary is increasing the demand for aquatic veterinary products and services.

Further, The adoption of AI, machine learning, and IoT-based technologies is transforming aquatic veterinary medicine. These innovations enable real-time monitoring of diseases, predictive analytics, and precise health management in aquaculture. They improve the early detection of pathogens and optimize treatment strategies, helping to reduce reliance on broad-spectrum antibiotics. For instance, the EU's Cure4Aqua project, which is ongoing until 2027, is developing AI-driven diagnostic platforms that accurately identify fish diseases, aiding veterinarians in managing outbreaks in species such as salmon and tilapia.

AI-powered solutions analyze vast amounts of data collected from IoT sensors, cameras, and biosensors placed in aquatic environments to continuously monitor water quality and fish health. Key parameters, including temperature, dissolved oxygen, pH, ammonia levels, and fish behavior, are tracked. AI algorithms can detect patterns and anomalies indicating disease outbreaks or environmental stress before they reach critical levels. This proactive approach allows for timely interventions, preventing mass mortality and minimizing economic losses. Therefore, the integration of AI and Internet of things in aquatic disease management are expected to be market trends and gain market share during the forecast period.

The comparative company analysis evaluates and categorizes the aquatic veterinary market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global aquatic veterinary market. The key market players are Esox Biologics Ltd, Zoetis Inc, Merck KGaA, HIPRA SA, Ceva Polchem Pvt Ltd, Virbac SA, Elanco Animal Health Inc, Phibro Animal Health Corp, Aquatic Diagnostics Ltd, and Thermo Fisher Scientific Inc.

Based on type, the market is segmented into diagnostic and treatment. The treatment segment held a larger aquatic veterinary market share in 2024 and is expected to register the highest CAGR during 2025-2031.

The global aquatic veterinary market, by species, is segmented into fish, crustaceans, mollusca, and others. The fish segment held the largest share of the aquatic veterinary market in 2024 and is expected to register a higher CAGR during 2025-2031.

In terms of diseases source, the global aquatic veterinary market is segmented into bacterial, viral, parasites, and others. The bacterial segment held the largest share of the aquatic veterinary market in 2024 and is anticipated to register the highest CAGR during 2025-2031.

The market, by route of administration, is segmented into water medication, medicated feed, and other route of administrations. The water medication segment held the largest share of the aquatic veterinary market in 2024.

Various organic and inorganic strategies are adopted by companies operating in the aquatic veterinary market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the aquatic veterinary market are listed below.